Home
Categories
EXPLORE
True Crime
Comedy
Society & Culture
Business
Sports
History
Fiction
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/c3/83/65/c3836550-2727-648f-a074-80e695f68db1/mza_6661645625389091452.jpg/600x600bb.jpg
7-2-1
The Foundation For Women and Girls With Blood Disorders
13 episodes
3 weeks ago
In this episode of The 7-2-1, Dr. Kemi Olaiya and Dr. Cheryl Mensah continue the conversation on fertility preservation in sickle cell disease with Dr. Leslie Appiah, a leading expert in fertility preservation. Together, they break down what patients, families, and providers need to know, from insurance coverage and the hematologist’s role, to special considerations like hydration, anesthesia risks, and ovarian hyperstimulation syndrome. The discussion also explores how common sickle cell tre...
Show more...
Medicine
Health & Fitness,
Sexuality
RSS
All content for 7-2-1 is the property of The Foundation For Women and Girls With Blood Disorders and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of The 7-2-1, Dr. Kemi Olaiya and Dr. Cheryl Mensah continue the conversation on fertility preservation in sickle cell disease with Dr. Leslie Appiah, a leading expert in fertility preservation. Together, they break down what patients, families, and providers need to know, from insurance coverage and the hematologist’s role, to special considerations like hydration, anesthesia risks, and ovarian hyperstimulation syndrome. The discussion also explores how common sickle cell tre...
Show more...
Medicine
Health & Fitness,
Sexuality
https://is1-ssl.mzstatic.com/image/thumb/Podcasts211/v4/c3/83/65/c3836550-2727-648f-a074-80e695f68db1/mza_6661645625389091452.jpg/600x600bb.jpg
Special Edition – How New Gene Therapies for SCD May Impact Women’s Fertility
7-2-1
10 minutes
1 year ago
Special Edition – How New Gene Therapies for SCD May Impact Women’s Fertility
As we closed 2023, the Food and Drug Administration (FDA) approved two gene therapies to treat sickle cell disease (SCD). These potential curative therapies include CASGEVY™ (exagamglogene autotemcel [exa-cel]) from Vertex Pharmaceuticals Incorporated and CRISPER Therapeutics, and LYFGENIATM from bluebirdbio. While there is a lot of excitement for these advances, the impacts of these therapies are not currently known. Like with many therapies, the impact on women and their future fertility ar...
7-2-1
In this episode of The 7-2-1, Dr. Kemi Olaiya and Dr. Cheryl Mensah continue the conversation on fertility preservation in sickle cell disease with Dr. Leslie Appiah, a leading expert in fertility preservation. Together, they break down what patients, families, and providers need to know, from insurance coverage and the hematologist’s role, to special considerations like hydration, anesthesia risks, and ovarian hyperstimulation syndrome. The discussion also explores how common sickle cell tre...